UK charity pockets $150 mln from Merck cancer immunotherapy drug

LONDON, July 15 (Reuters) - British medical charity MRC

Technology has pocketed $150 million by selling part of its

royalty interest in Merck & Co's successful cancer drug

Keytruda, allowing it to...

Read more